Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | 0.00% | +6.81% | -59.19% |
01/05 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
27/02 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.19% | 17.55M | |
+2.94% | 108B | |
+10.36% | 105B | |
+1.57% | 23.46B | |
-12.04% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.81% | 17.19B | |
+6.40% | 13.99B | |
+36.93% | 12.53B |
- Stock Market
- Equities
- NERV Stock
- News Minerva Neurosciences, Inc.
- FDA Files Minerva Neurosciences's NDA for Roluperidone to Treat Schizophrenia Symptoms; Shares Jump 61% Midday